Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Nonfilamentous C. albicans Mutants Are Avirulent
- H. Lo, J. Köhler, B. Didomenico, D. Loebenberg, A. Cacciapuoti, G. Fink
- BiologyCell
- 5 September 1997
In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts
- F. Sabatelli, R. Patel, P. McNicholas
- Biology, MedicineAntimicrobial Agents and Chemotherapy
- 1 June 2006
TLDR
Three-Dimensional Models of Wild-Type and Mutated Forms of Cytochrome P450 14α-Sterol Demethylases from Aspergillus fumigatus and Candida albicans Provide Insights into Posaconazole Binding
- Li Xiao, V. Madison, A. Chau, D. Loebenberg, R. Palermo, P. McNicholas
- Biology, ChemistryAntimicrobial Agents and Chemotherapy
- 1 February 2004
ABSTRACT The cytochrome P450 sterol 14α-demethylase enzyme (CYP51) is the target of azole antifungals. Azoles block ergosterol synthesis, and thereby fungal growth, by binding in the active-site…
Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase
- P. Mann, R. Parmegiani, P. McNicholas
- Biology, MedicineAntimicrobial Agents and Chemotherapy
- 1 February 2003
TLDR
Comparison of Pathogenesis and Host Immune Responses to Candida glabrata and Candida albicans in Systemically Infected Immunocompetent Mice
- J. Brieland, David Essig, Robert V. Hare
- Biology, MedicineInfection and Immunity
- 1 August 2001
TLDR
Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles
- A. Chau, C. Mendrick, F. Sabatelli, D. Loebenberg, P. McNicholas
- Biology, MedicineAntimicrobial Agents and Chemotherapy
- 1 June 2004
TLDR
Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated Candidiasis
- D. Andes, K. Marchillo, D. Loebenberg
- Biology, MedicineAntimicrobial Agents and Chemotherapy
- 1 January 2004
TLDR
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
- E. Dannaoui, J. Meis, D. Loebenberg, P. Verweij
- BiologyAntimicrobial Agents and Chemotherapy
- 1 November 2003
TLDR
EmtA, a rRNA methyltransferase conferring high‐level evernimicin resistance
- P. Mann, L. Xiong, P. McNicholas
- BiologyMolecular microbiology
- 1 September 2001
TLDR
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH…
- E. Manavathu, J. Cutright, D. Loebenberg, P. Chandrasekar
- Biology, MedicineThe Journal of antimicrobial chemotherapy
- 1 August 2000
TLDR
...
1
2
3
4
5
...